986 Followers on Owler

Fulgent

focuses on developing and commercializing novel formulations of anti-cancer therapeutics... Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Fulgent

focuses on developing and commercializing novel formulations of anti-cancer therapeutics... Read more
Fulgent Chairman & CEO: Ming Hsieh

Chairman & CEO

Ming Hsieh

CEO Approval Rating

94/100

2011

PublicNASDAQFLGT

Pharmaceuticals & Biotechnology
Medical Research & Laboratories
2834 NAICS listing

Annual Revenue
$320.3M
Employees
1,010
Funding
$67.2M
Acquisitions
6
Investments
1

News

Acquisition
Dec 23, 2025
citybiz.co
Fulgent acquired StrataDx for undisclosed amount

Fulgent Competitors

1Natera
2GeneDX
3Myriad Genetics
4Invitae
5Quest Diagnostics
6Labcorp
7Abbott
8PerkinElmer
9Sema4
10Ambry
Unlock 24 + competitors

Trending Companies